Please assess the completion status of the following clinical trial:

Trial Title: Anesthesic Propofol and Remifentanil Requirements in Obese Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Patients scheduled for a bariatric coelioscopic surgical procedure (obese patients) or for an upper abdominal laparoscopic procedure (lean patients)~Exclusion Criteria:~* age lower than 18 years,~* pregnant woman,~* presence of a central neurological disorder or a lesion cerebral, of a severe respiratory or hepatic insufficiency,~* allergy to propofol, or to soja or to peanuts, or to sufentanil, or to remifentanil, or to morphine, or to a muscle myorelaxant, or to an excipient,~* hypersensibility to sufentanil, or to remifentanil or to another derivate of fentanyl,~* allergy to latex,~* presence of a symptomatic gastroesophageal reflux,~* patients receiving a psychotropic treatment or a agonist-antagonist opiate,~* presence of predictive signs of difficult mask ventilation of difficult intubation (else than obesity)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): obese patients
- 2 (Type: ACTIVE_COMPARATOR): lean patients

Based on this trial design, predict the completion outcome and termination type (if applicable).